Clinical Trial

Neuroimaging of Cognitive Behavioral Therapy in Fibromyalgia

Study Description

Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia

This study design has two components: 1) a cross sectional assessment of brain connectivity and response to pain in healthy controls and demographically matched fibromyalgia patients, and 2) a longitudinal assessment of the same outcomes in fibromyalgia patients randomized to either CBT (Cognitive Behavioral Therapy) or a Disease Education condition. The investigators will evaluate 90 fibromyalgia patients who will receive CBT treatment once a week for 8 weeks, for a total of 8 treatments. Baseline data from these patients will be compared to results from 30 pain-free controls and 60 education program controls. Participants will undergo experimental pain assessments as well as brain neuroimaging.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - Cognitive Behavioral Therapy

Practicing certain strategies such as relaxation and changing negative thoughts about pain.

Behavioral - Education

Giving participants information about pain and how to change perceptions of pain.

Additional Information

Official Study Title

Neuroimaging Effects of Cognitive Behavioral Therapy in Fibromyalgia

Clinical Trial ID

NCT01345344

ParticipAid ID

RdG50a